Seventeen-year follow-up of the prospective randomized Nordic CIS study: BCG monotherapy versus alternating therapy with mitomycin C and BCG in patients with carcinoma in situ of the urinary bladder

Eero Kaasinen , Hans Wijkstrom, Erkki Rintala, Oddvar Mestad, Staffan Jahnson, Per-Uno Malmstrom

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalScandinavian Journal of Urology
Volume50
Issue number5
Pages (from-to)360-368
Number of pages9
ISSN2168-1805
DOIs
Publication statusPublished - Oct 2016
MoE publication typeA1 Journal article-refereed

Fields of Science

  • BCG
  • carcinoma in situ
  • combination therapy
  • immunotherapy
  • instillation therapy
  • long-term efficacy
  • mitomycin C
  • randomized controlled trial
  • urinary bladder
  • BACILLUS-CALMETTE-GUERIN
  • PHASE-III TRIAL
  • ELECTROMOTIVE MITOMYCIN
  • UROTHELIAL CARCINOMA
  • PROGNOSTIC-FACTORS
  • CANCER
  • RISK
  • T1
  • MAINTENANCE
  • PROGRESSION
  • 3126 Surgery, anesthesiology, intensive care, radiology

Cite this